Sara Elford

Sara Elford discloses dealings in BioSyent Inc. to SEDI. We count 12 filings; the first trade dates from 3 June 2019 and the latest from 1 October 2026.

On the market, this insider has only ever bought: 3 purchases, €3,999 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 9 option exercises.

Half of the purchases are above €1,317 and half below. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The record was last updated on 2 October 2026 with an option exercise (€3,536) in BioSyent Inc. The last insider purchase was made public on 24 June 2019, 2,683 days ago. Publication is fast: at least half of the trades appear on SEDI on the same day. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.